Nanomedicine research into drug delivery system a 'milestone' in the treatment of childhood cancer
Published this week in Science Translational Medicine, the research paves the way to safer and more effective treatment options for ...
May 18, 2023
Identifying drug target candidates to treat pediatric rhabdomyosarcoma tumors
In a new report in Science Advances, Sara G. Danielli and an international, interdisciplinary team of scientists at the department of ...
Feb 23, 2023
New drug combination may effectively treat often fatal childhood brain tumor
Researchers at the University of Colorado Anschutz Medical Campus and partners become first to treat MYC amplified Medulloblastoma on a...
Jan 17, 2023
New Drug Shows ‘Encouraging’ Outcomes for Pediatric Brain Tumor Treatment
Treatment with tovorafenib led to a 64% overall response rate in patients with recurrent or progressive pediatric low-grade glioma, study...
Jan 12, 2023
Drug Response Study of Leukemia Subtypes Advances Precise Patient-Therapy Matching
A study by researchers at St. Jude Children’s Research Hospital delving into drug response across a swath of genetic subtypes of acute...
Jan 6, 2023
Why Do Pediatric Drugs Take So Long to Develop?
When it comes to treatment for cancer, and many chronic conditions in children, it often takes much longer to get new drugs and therapies...
Jul 19, 2022
Bortezomib extends survival of children with newly diagnosed T-cell lymphoblastic lymphoma
The addition of bortezomib to chemotherapy significantly improved survival outcomes among children and young adults with T-cell ...
Jun 16, 2022
FDA Approves Rare Pediatric Disease Designation for IMX-110 for Rhabdomyosarcoma
Officials with the FDA have approved a Rare Pediatric Disease Designation for IMX-110 for the treatment of pediatric patients with ...
Jan 19, 2022
FDA Approves Rylaze as Alternative for Patients with ALL and Lymphoblastic Lymphoma
New FDA approval means that pediatric and adult patients with acute lymphoblastic leukemia (ALL) and lympoblastic lymphoma who are...
Jul 2, 2021
Pediatric cancers have unique genetic vulnerabilities
Most cancer drugs that target specific genetic mutations are designed for adult cancers rather than those in children, partly because ...
Mar 26, 2021